Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Detection of Rickettsia helvetica in Ixodes ricinus infesting wild and domestic animals and in a botfly larva (Cephenemyia stimulator) infesting roe deer in Germany.

Scheid P, Speck S, Schwarzenberger R, Litzinger M, Balczun C, Dobler G.

Ticks Tick Borne Dis. 2016 Oct;7(6):1268-1273. doi: 10.1016/j.ttbdis.2016.07.002. Epub 2016 Jul 5.

PMID:
27430966
2.

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

Palena C, Roselli M, Litzinger MT, Ferroni P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI, Hamilton DH, Jochems C, Tsang KY, Cheng Q, Lyerly HK, Schlom J, Guadagni F.

J Natl Cancer Inst. 2014 May 9;106(5). pii: dju054. doi: 10.1093/jnci/dju054.

3.

Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.

Hamilton DH, Litzinger MT, Jales A, Huang B, Fernando RI, Hodge JW, Ardiani A, Apelian D, Schlom J, Palena C.

Oncotarget. 2013 Oct;4(10):1777-90.

4.

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies.

Huang B, Cohen JR, Fernando RI, Hamilton DH, Litzinger MT, Hodge JW, Palena C.

Cell Death Dis. 2013 Jun 20;4:e682. doi: 10.1038/cddis.2013.208.

5.

Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.

Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton D, Huang B, Tucker J, Tsang KY, Schlom J, Palena C.

Clin Cancer Res. 2012 Jul 15;18(14):3868-79. doi: 10.1158/1078-0432.CCR-11-3211. Epub 2012 May 18.

6.

Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.

Hamilton DH, Litzinger MT, Fernando RI, Huang B, Palena C.

Semin Oncol. 2012 Jun;39(3):358-66. doi: 10.1053/j.seminoncol.2012.02.005. Review.

7.

IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.

Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C.

Cancer Res. 2011 Aug 1;71(15):5296-306. doi: 10.1158/0008-5472.CAN-11-0156. Epub 2011 Jun 8.

8.

Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells.

Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B, Schlom J.

Exp Biol Med (Maywood). 2011 May 1;236(5):537-45. doi: 10.1258/ebm.2011.010367. Epub 2011 Mar 22. Review.

9.

Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia.

Muramatsu RS, Litzinger MH, Fisher E, Takeshita J.

Am J Geriatr Pharmacother. 2010 Apr;8(2):98-114. doi: 10.1016/j.amjopharm.2010.03.003. Review.

PMID:
20439060
10.

Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.

Litzinger MT, Foon KA, Tsang KY, Schlom J, Palena C.

Leuk Res. 2010 Oct;34(10):1351-7. doi: 10.1016/j.leukres.2009.12.013. Epub 2010 Jan 31.

11.

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.

Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J, Palena C.

J Clin Invest. 2010 Feb;120(2):533-44. doi: 10.1172/JCI38379. Epub 2010 Jan 11.

12.

Serotonin syndrome associated with tramadol.

Takeshita J, Litzinger MH.

Prim Care Companion J Clin Psychiatry. 2009;11(5):273. doi: 10.4088/PCC.08l00690. No abstract available.

13.

Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

Litzinger MT, Foon KA, Sabzevari H, Tsang KY, Schlom J, Palena C.

Cancer Immunol Immunother. 2009 Jun;58(6):955-65. doi: 10.1007/s00262-008-0611-5. Epub 2008 Nov 14.

14.

Clinical safety of a viral vector based prostate cancer vaccine strategy.

Arlen PM, Skarupa L, Pazdur M, Seetharam M, Tsang KY, Grosenbach DW, Feldman J, Poole DJ, Litzinger M, Steinberg SM, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley JL.

J Urol. 2007 Oct;178(4 Pt 1):1515-20. Epub 2007 Aug 16.

PMID:
17707059
15.

IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.

Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C.

Blood. 2007 Nov 1;110(9):3192-201. Epub 2007 Jul 6.

16.

The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.

Palena C, Polev DE, Tsang KY, Fernando RI, Litzinger M, Krukovskaya LL, Baranova AV, Kozlov AP, Schlom J.

Clin Cancer Res. 2007 Apr 15;13(8):2471-8.

17.

Oxcarbazepine in infants and young children with partial seizures.

Northam RS, Hernandez AW, Litzinger MJ, Minecan DN, Glauser TA, Mangat S, Zheng C, Souppart C, Sturm Y.

Pediatr Neurol. 2005 Nov;33(5):337-44.

PMID:
16243221
18.

Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction.

Litzinger MT, Su Y, Lei TC, Soukhareva N, Scott DW.

J Immunol. 2005 Jul 15;175(2):780-7.

19.

Complexity of focal spikes suggests relative epileptogenicity.

Rodin E, Litzinger M, Thompson J.

Epilepsia. 1995 Nov;36(11):1078-83.

PMID:
7588451
20.

Voltage-sensitive calcium channel development in epileptic DBA/2J mice suggests altered presynaptic function.

Esplin MS, Abbott JR, Smart ML, Burroughs AF, Frandsen TC, Litzinger MJ.

Epilepsia. 1994 Sep-Oct;35(5):911-4.

PMID:
7925160
22.

Regional differences in the critical period neurodevelopment in the mouse: implications for neonatal seizures.

Litzinger MJ, Mouritsen CL, Grover BB, Esplin MS, Abbott JR.

J Child Neurol. 1994 Jan;9(1):77-80.

PMID:
8151090
23.

Voltage sensitive calcium channels mark a critical period in mouse neurodevelopment.

Litzinger MJ, Grover BB, Saderup S, Abbott JR.

Int J Dev Neurosci. 1993 Feb;11(1):17-24.

PMID:
8387720
24.
25.
26.
27.

[3H]-tetrodotoxin binding in neuronal and non-neuronal spinal cord cultures.

Litzinger MJ, Lombet A, Brenneman DE, Lazdunski M.

Biochem Biophys Res Commun. 1986 Aug 14;138(3):1250-6.

PMID:
2428363
28.

[H3]-nitrendipine binding in non-neuronal cell cultures.

Litzinger MJ, Foster G, Brenneman DE.

Biochem Biophys Res Commun. 1986 Apr 29;136(2):783-8.

PMID:
2939834
29.

Neuronal survival during electrical blockade is increased by 8-bromo cyclic adenosine 3',5' monophosphate.

Brenneman DE, Fitzgerald S, Litzinger MJ.

J Pharmacol Exp Ther. 1985 May;233(2):402-8.

PMID:
2987479
30.

[3H]-Nitrendipine binding in developing dissociated fetal mouse spinal cord neurons.

Litzinger MJ, Brenneman DE.

Biochem Biophys Res Commun. 1985 Feb 28;127(1):112-9.

PMID:
3156593
31.

Effects of nitrendipine on the voltage-sensitive calcium channel in mammalian sensory neurons.

Litzinger MJ, Nelson PG, Pun RY.

J Neurosci Res. 1985;14(4):415-22.

PMID:
2416944
32.

TTX displacement of [H3]-nitrendipine binding in developing spinal cord neurons.

Litzinger MJ, Brenneman DE.

Biochem Biophys Res Commun. 1984 Nov 14;124(3):979-87.

PMID:
6508790
33.

A survey of the review programs for the Part 1 exam of the National Board of Medical Examiners.

Litzinger MJ, Welker WJ.

J Med Educ. 1979 Feb;54(2):111-2. No abstract available.

PMID:
762688

Supplemental Content

Loading ...
Support Center